Organon’s $954 Million Acquisition of Forendo Pharma

Krogerus and Wilmer Cutler Pickering Hale and Dorr advised Forendo Pharma on the deal. Organon, a global healthcare company formed through a spin-off from Merck, is…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here
Federica Tiefenthaler

Author: Federica Tiefenthaler

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here